November 17, 2020
By Tom Bergeron
Dr. Shobha Swaminathan is an associate professor at Rutgers New Jersey Medical School and medical director of infectious diseases practice at University Hospital. This week, she is better known for being the principal investigator for the Moderna Phase 3 coronavirus vaccine clinical trial at the school.
October 30, 2020
By Newswise
Journalists and editors are invited to attend this live virtual event and ask questions either on camera or we can relay your questions to the panelists. Register to attend and receive the on-demand recording after the session is concluded.
September 16, 2020
By Korin Miller
By now, you’re probably well aware of the most common symptoms of COVID-19, including a fever, cough, overwhelming fatigue, loss of taste or smell, and GI issues like diarrhea.
September 1, 2020
By Zach Hosseini
New Jersey Medical School (NJMS) has been selected by Moderna as one of over 90 sites across the United States to recruit adults to volunteer for the COVID-19 vaccine trial (known as the COVE Study) that will test the safety and effectiveness of the vaccine in approximately 30,000 participants nationwide.
September 1, 2020
By Out In Jersey
August 31, 2020
By Raven Santana, Correspondent
Posted Mon, Aug. 31, 2020; Updated Mon, Jan. 4 2021
By Eric Klefer, Patch Staff
August 30, 2020
By Insider NJ
The following is a statement issued Sunday night by Newark Mayor Ras Baraka in response to a COVID-19 vaccine clinical trial:
Updated August 27, 2020; Posted Aug. 27. 2020
By Katie Kausch | NJ Advance Media for NJ.com
A coronavirus vaccine trial is looking for healthy volunteers in New Jersey as part of a Stage 3 clinical research study.
The trial is part of Moderna’s COVE Study, which will involve giving 30,000 people at 89 different testing sites across the country either a vaccine or a placebo dose.
May 18, 2020
By Jon Cohen
It’s not an AIDS vaccine but it may be the closest thing to one so far. A long-acting antiretroviral drug given as an injection every 2 months powerfully protected uninfected people from HIV in a large-scale study that was disrupted by the COVID-19 pandemic. The apparent success—the study has not been published in a peer-reviewed journal or presented to HIV researchers at a meeting—offers a potentially easier alternative to taking daily pills of other antiretrovirals, which has proved difficult for many people.
April 27, 2020
By TrialSite Staff
Rutgers New Jersey Medical School Clinical Research Center represents the only clinical investigational site in New Jersey to participate in the Phase III HIV vaccine clinical trial known as MOSAICO. Dr. Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases, notes on this study, “While we are making encouraging progress in preventing new HIV infections, the development of a safe and effective HIV vaccine would be the ultimate game-changer.” Rutgers has developed an effective community engagement model for their research operation.
April 25, 2020
By Lana Leonard
“While we are making encouraging progress in preventing new HIV infections, the development of a safe and effective HIV vaccine would be the ultimate game-changer” says Dr. Anthony Fauci, Director of the National Institute of Allergy and Infectious Diseases.
Feb. 20, 2020
By Madison McGay
The Rutgers New Jersey Medical School (NJMS) Clinical Research Center will participate in a global attempt at enrolling 3,800 people who have tested HIV negative in the first Phase 3 HIV efficacy trial conducted in more than a decade, according to an article on Rutgers Today.
Feb. 20, 2020
By Madison McGay
The Rutgers New Jersey Medical School (NJMS) Clinical Research Center will participate in a global attempt at enrolling 3,800 people who have tested HIV negative in the first Phase 3 HIV efficacy trial conducted in more than a decade, according to an article on Rutgers Today.
Feb. 11, 2020
By Travis Love
“The search for a vaccine began the moment HIV was first identified over 35 years ago, but there have been many challenges along the way due to the unique properties of this virus, including its global genetic diversity,” said Johan Van Hoof, M.D., Global Therapeutic Area Head, Vaccines, and Managing Director, Janssen Vaccines & Prevention B.V., Janssen Pharmaceuticals NV. The Undetectable Equals Untransmitable (U=U) campaign, Treatment as Prevention, and the addition of PrEP and PEP have helped prevent new infections. However, there are still some pockets with high rates of HIV infection in some parts of the US.
October 20, 2018
By Peter Frycki
The Rutgers New Jersey Medical School Clinical Research Center (NJMS CRC) will sponsor In Conversation: Infinite Possibilities. It is a free event in collaboration with the Newark Museum and The Center for Transgender Health. Trailblazers contributing their stories include trans activist Tyra Gardner, Khloyei Chanel, and supermodel Tracey Africa Norman.
April 27, 2018
By Tehsuan Glover
Founded by award-winning advocate, DaShawn Usher and peer-led by a group of black queer men, the Newark edition of MOBItalks is a partnership with the Rutgers New Jersey Medical School Clinical Research Center and North Jersey Community Research Initiative, featuring moving talks with LGBTQ influencers including: Kiki Ball icon, Kodak; Joseph Williams, The Misunderstood Social Worker; Reverend Kevin Taylor; and performer, Harmonica Sunbeam.